Jürgen Gerlach

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.

Panoratio Database Images GmbH engages in the development of software for the interpretation and analysis of data structures. The company was founded by Michael Haft and Reimar Hofmann in 2003 and is headquartered in Stuttgart, Germany.

Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.

PHOENIX CONTACT Cyber Security GmbH engages in the development and manufacture of connection and automation technology for use in industrial environments. Its products include lighting and signaling, electronics housing, electronic switching devices and motor control, functional safety, HMIs and industrial PCs, industrial cloud computing, industrial communication technology, installation and assembly material, cables and wires, charging technology for electric mobility, PCB terminals and connectors, marking and labeling utensils, measurement, control and regulation technology. The company was founded on August 28, 2001 and is headquartered in Berlin, Germany.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.

XAnge Private Equity SA (XAnge Private Equity) is a private equity portfolio management firm which was created in 2003 by La Poste and ABN AMRO and is headquartered in France.

TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom.

Efficas Medical Foods & Nutrition LLC develops science-based consumer products for the nutritional management of the immune system for both humans and pets. Its products are non-prescription medical food and helps to provide relief from asthma and associated allergies. The company was founded by Nancy Fogg-Johnson and Alex Merolli in 2003 and is headquartered in Fullerton, CA.

Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

Siparex XAnge Venture SAS is an Independent Venture Capital firm founded in 1977 by Benjamin Teszner. Siparex XAnge Venture SAS is headquartered in Paris.

Apertio Ltd. provides subscriber-centric networks for mobile, fixed and converged telecommunications operators. Its software application suite, Apertio One, delivers a single, open, subscriber-centric architecture for current and new generation networks. The company was founded by Paul J. Magelli Jr., Geoffrey Phillips, Kevin Wakefield, Paul Donnelly, Wallace P. Ascham and Michael Welbourne in 2002 and is headquartered in Bristol, the United Kingdom.

VisionOSS Ltd. develops solutions for businesses with IP telephony and unified communications requirements. It provides web-based administration, lifecycle and service management, business process orchestration, data abstraction, and communication architecture technologies. The company was founded by Stefan Peters, Ian Middleton, Derek Lipscombe, Christopher May and Henry Barton on March 19, 2003 and is headquartered in Reading, the United Kingdom.

VISIONOSS, Inc. provides service delivery and management software. Its products includes VOSS-4-UC, M2UC, and VOSS Assurance. The company was founded by Henry Barton, Christopher May, Stefan Peters, Ian Middleton and Derek Lipscombe in 2003 and is headquartered in Richardson, TX.

Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany.

APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland.

EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland.

Lydia Solutions SAS offers mobile payment solutions using quick response code. It offers bank transfers, create online money pots, and set recurring payments. The company was founded by Antoine Porte and Cyril Chiche in 2013 and is headquartered in Paris, France.

Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.

Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada.

Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland.

Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany.